These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8858104)

  • 1. Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells.
    Tsai H; Werber J; Davia MO; Edelman M; Tanaka KE; Melman A; Christ GJ; Geliebter J
    Biochem Biophys Res Commun; 1996 Oct; 227(1):64-9. PubMed ID: 8858104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
    Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
    Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of human prostate cancer cell growth by forced expression of connexin genes.
    Mehta PP; Perez-Stable C; Nadji M; Mian M; Asotra K; Roos BA
    Dev Genet; 1999; 24(1-2):91-110. PubMed ID: 10079514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
    Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
    Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
    Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR
    Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer.
    Habermann H; Ray V; Habermann W; Prins GS
    J Urol; 2001 Dec; 166(6):2267-72. PubMed ID: 11696749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
    Guo Y; Sklar GN; Borkowski A; Kyprianou N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma.
    Collett GP; Betts AM; Johnson MI; Pulimood AB; Cook S; Neal DE; Robson CN
    Clin Cancer Res; 2000 Aug; 6(8):3241-8. PubMed ID: 10955810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis.
    Cheung PK; Woolcock B; Adomat H; Sutcliffe M; Bainbridge TC; Jones EC; Webber D; Kinahan T; Sadar M; Gleave ME; Vielkind J
    Cancer Res; 2004 Sep; 64(17):5929-33. PubMed ID: 15342369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue.
    Hobisch A; Rogatsch H; Hittmair A; Fuchs D; Bartsch G; Klocker H; Bartsch G; Culig Z
    J Pathol; 2000 Jul; 191(3):239-44. PubMed ID: 10878544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.
    Ruiz M; Troncoso P; Bruns C; Bar-Eli M
    Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
    Altinok G; Powell IJ; Che M; Hormont K; Sarkar FH; Sakr WA; Grignon D; Liao DJ
    Prostate Cancer Prostatic Dis; 2006; 9(1):77-82. PubMed ID: 16331298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer.
    Habermann H; Ray V; Habermann W; Prins GS
    J Urol; 2002 Feb; 167(2 Pt 1):655-60. PubMed ID: 11792947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
    Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC
    Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.